[A reference to know: the 2008 Chest Supplement on antithrombotic agents].
Almost every four years a Supplement of Chest about the use of antithrombotic agents is published. The recommendations come from international experts who deal among others with the use of these drugs in case of venous thromboembolic disease, atrial fibrillation, valvular and structural heart diseases, ischemic stroke, coronary diseases and peripheral artery occlusive disease. We review some recommendations about the appropriate use of anticoagulants to prevent and treat venous thromboembolic diseases as well as the use of antiplatelet agents in case of arterial diseases.
de Moerloose
Philippe
P
Unité d'hémostase, Département de médecine interne, Faculté de médecine de Genève HUG, 1211 Genève 14.
Fontana
Pierre
P
Boehlen
Françoise
F
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010506:Periodicals as Topic; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D054556:Venous Thromboembolism / Q000188:drug therapy
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors